0.0060
+0.0010
+(20.00%)
At close: January 10 at 3:00:00 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
165,728.0000
159,237.0000
163,213.0000
203,018.0000
151,669.0000
Cost of Revenue
93,834.0000
96,068.0000
88,781.0000
93,490.0000
69,829.0000
Gross Profit
71,894.0000
63,169.0000
74,432.0000
109,528.0000
81,840.0000
Operating Expense
85,702.0000
92,199.0000
140,280.0000
127,484.0000
139,194.0000
Operating Income
-13,808.0000
-29,030.0000
-65,848.0000
-17,956.0000
-57,354.0000
Net Non Operating Interest Income Expense
-26,714.0000
-28,312.0000
-12,814.0000
-32,155.0000
-37,244.0000
Other Income Expense
77.0000
-2,579.0000
-360,038.0000
-5,643.0000
-200,131.0000
Pretax Income
-40,446.0000
-59,921.0000
-438,700.0000
-55,754.0000
-294,729.0000
Tax Provision
13,678.0000
16,700.0000
10,691.0000
21,736.0000
18,633.0000
Net Income Common Stockholders
-54,124.0000
-76,621.0000
-449,391.0000
-77,490.0000
-313,362.0000
Diluted NI Available to Com Stockholders
-54,124.0000
-76,621.0000
-449,391.0000
-77,490.0000
-313,362.0000
Basic EPS
-0.01
-0.01
-0.13
-0.45
-1.83
Diluted EPS
-0.01
-0.01
-0.13
-0.45
-1.83
Basic Average Shares
6,518,712.5000
6,437,450.0000
3,371,545.0000
171,718.0000
171,649.0000
Diluted Average Shares
6,518,712.5000
6,437,450.0000
3,371,545.0000
171,718.0000
171,649.0000
Total Operating Income as Reported
-23,964.0000
-40,710.0000
-112,455.0000
-23,780.0000
-249,891.0000
Total Expenses
179,536.0000
188,267.0000
229,061.0000
220,974.0000
209,023.0000
Net Income from Continuing & Discontinued Operation
-54,124.0000
-76,621.0000
-449,391.0000
-77,490.0000
-313,362.0000
Normalized Income
-54,184.8300
-74,583.5900
-164,960.9800
-72,222.3200
-166,531.2600
Interest Income
5,019.0000
1,846.0000
13,806.0000
517.0000
403.0000
Interest Expense
31,733.0000
30,158.0000
26,620.0000
32,672.0000
37,647.0000
Net Interest Income
-26,714.0000
-28,312.0000
-12,814.0000
-32,155.0000
-37,244.0000
EBIT
-8,713.0000
-29,763.0000
-412,080.0000
-23,082.0000
-257,082.0000
EBITDA
16,751.0000
-2,593.0000
-380,690.0000
7,958.0000
-229,162.0000
Reconciled Cost of Revenue
93,833.0000
96,068.0000
88,781.0000
93,489.0000
68,098.0000
Reconciled Depreciation
25,464.0000
27,170.0000
31,390.0000
31,040.0000
27,920.0000
Net Income from Continuing Operation Net Minority Interest
-54,124.0000
-76,621.0000
-449,391.0000
-77,490.0000
-313,362.0000
Total Unusual Items Excluding Goodwill
77.0000
-2,579.0000
-360,038.0000
-7,216.0000
-201,138.0000
Total Unusual Items
77.0000
-2,579.0000
-360,038.0000
-7,216.0000
-201,138.0000
Normalized EBITDA
16,674.0000
-14.0000
-20,652.0000
15,174.0000
-28,024.0000
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0003
0.0003
Tax Effect of Unusual Items
16.1700
-541.5900
-75,607.9800
-1,948.3200
-54,307.2600
12/31/2020 - 3/2/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
TLLTF TILT Holdings Inc.
0.0050
-5.66%
CNTMF Cansortium Inc.
0.0860
+2.38%
ETRGF Entourage Health Corp.
0.0052
+3.20%
NTRR Neutra Corp.
0.0003
0.00%
FFNTF 4Front Ventures Corp.
0.0110
+1.85%
CBWTF Auxly Cannabis Group Inc.
0.0350
+1.16%
TIUM-U.CN Cansortium Inc.
0.0850
0.00%
VREOF Vireo Growth Inc.
0.5450
+0.09%
MRMD MariMed Inc.
0.1110
-0.18%
GGBXF Green Growth Brands Inc.
0.0000
0.00%